Anthony S. Fauci, M.D., was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted diseases, influenza, tuberculosis, malaria, and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma, and allergies. The NIAID budget for fiscal year 2015 is approximately $4.4 billion. Dr. Fauci serves as one of the key advisors to the White House and U.S. Department of Health and Human Services on global AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza.
Zika Virus Infection and Zika-Associated Fetal Infection/Microcephaly (article in Harrison's Principles of Internal Medicine online, co-authored by Dr. David M. Morens)—Feb. 8, 2016
Zika Virus in the Americas — Yet Another Arbovirus Threat (commentary in The England Journal of Medicine, co-authored by Dr. David M. Morens)—Jan. 13, 2016
No More Excuses. We Have the Tools to End the HIV/AIDS Pandemic. (commentary in the Washington Post)—Jan. 10, 2016
Video: Dr. Fauci's presentation at White House World AIDS Day event, "Ending the HIV/AIDS Pandemic: Follow the Science"—Dec. 1, 2015
Dr. Fauci is Chief of the Laboratory of Immunoregulation (LIR). LIR researches cellular and molecular mechanisms regulating the human immune response in health and disease, especially the immunopathogenic mechanisms of HIV infection and disease progression. Read more about LIR.
Last Updated February 09, 2016